Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-09-13
2011-11-29
Desai, Anand (Department: 1656)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S252100, C435S325000
Reexamination Certificate
active
08067557
ABSTRACT:
This invention relates to osteoclast-specific genes and proteins. Specifically, the invention relates to OCL-2A3 or Atp6v0d2, the gene encoding it and uses thereof in methods and treatment of bone disorders.
REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 1 087 230 AI (2001-03-01), None
patent: 2001122798 (2001-08-01), None
patent: WO 88/00205 (1988-01-01), None
patent: WO 00/13024 (2000-03-01), None
Abe, E., Mocharla, H., Yamate, T., Taguchi, Y. & Manolagas, S. C. Meltrin-alpha, a fusion protein involved in multinucleated giant cell and osteoclast formation. Calcif Tissue Int 64, 508-515 (1999).
Centrella et al., “Transforming Growth Factor (3 Is a Bifunctional Regulator of Replication and Collagen Synthesis in Osteoblast-enriched Cell Cultures from Fetal Rat Bone”, J. Biol. Chem. 1987 262 (6) :2869-2874.
Chen, E. H. & Olson, E. N. Unveiling the mechanisms of cell-cell fusion. Science 308, 369-373 (2005).
Chenu et al., “Transforming growth factor (3 inhibits formation of osteoclast-like cells in long-term human marrow cultures”, Proc. Natl. Acad. Sci. USA 1988 85:5683-5687.
Choi, S. J., Han, J. H. & Roodman, G. D. ADAM8: a novel osteoclast stimulating factor. J Bone Miner Res 16, 814-822 (2001).
Hsu et al., “Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osfceoprotegerin ligand”, Proc. Natl. Acad. Sci. USA 1999 96:3540-3545.
Hunt et al., “Cellular mechanisms of bone resorption in breast carcinoma”, British Journal of Cancer 2001 35 (1).
Isgaard et al., “Effects of local administration of GH and IGF-1 on longitudinal bone growth in rats”, Am. J. Physiol. 250 (Endocrinol. Metab. 13):E367-E372 1986.
Jacquin, C., Gran, D. E., Lee, S. K, Lorenzo, J. A & Aguila, H. L Identification of multiple osteoclast precursor populations in murine bone marrow. J Bone Miner Res 21, 67-77 (2006).
Joyce et al., “Transforming Growth Factor-(3 and the Initiation of Chondrogenesis and Osteogenesis in the Rat Femur”, J. Cell Biology 1990 110:2195-2207.
Kadono, Y. et al. Strength of TRAF6 signalling determines osteoclastogenesis. EMBO Rep 6, 171-176 (2005).
Kiebzak et al., “Bone Status of Senescent Female Rats:Chemical, Morphometric, and Biomechanical Analyses”, J. Bone and Mineral Research 1988 3(4):439-446.
Kim et al., “A Novel Member of the Leukocyte Receptor Complex Regulates Osteoclast ifferentiation1”, J. Exp, Med. 2002 195:201-209.
Kohler and Milstein, “Continuous cultures of fused cells secreting antibody of predefined specificity”, Nature 1975 256:495-497.
Kontani, K, Moskowitz, I. P. & Rothman, J. H. Repression of cell-cell fusion by components of the C. elegans vacuolar ATPase complex. Dev Cell 8, 787-794 (2005).
Kozbor and Roder, “The production of monoclonal antibodies from human lymphocytes”, Immunology Today 1983 4 (3) :72-79.
Lee, S. K et al. Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss. J Bone Miner Res 21, 695-702 (2006).
Li, Y. P., Chen, W., Liang, Y., Li, E. & Stashenko, P. Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat Genet 23, 447-451 (1999).
Mohler, W. A. et al. The type I membrane protein EFF-1 is essential for developmental cell fusion. Dev Cell 2, 355-362 (2002).
Montero, A. et al. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest 105, 1085-1093 (2000).
Nishi, T. & Forgac, M. The vacuolar (H+)-ATPases—nature's most versatile proton pumps. Nat Rev Mol Cell Biol 3, 94-103 (2002).
Nishi, T., Kawasaki-Nishi, S. & Forgac, M. Expression and function of the mouse V-ATPase d subunit isoforms. J Biol Chem 278, 46396-46402 (2003).
Noda and Camilliere, “In Vivo Stimulation of Bone Formation by Transforming Growth Factor-f5”, Endocrinology 1989 124:2991-2294.
Rho, J. et al. Gene expression profiling of osteoclast differentiation by combined suppression subtractive hybridization (SSH) and cDNA microarray analysis. DNA Cell Biol 21, 541-549 (2002).
Rho, J., Gong, S., Kim, N. & Choi, Y. TDAG51 is not essential for Fas/CD95 regulation and apoptosis in vivo. Mol Cell Biol 21, 8365-8370 (2001).
Slovik et al., “Restoration of Spinal Bone in Osteoporotic Men by Treatment with Human Parathyroid Hormone (1-34) and 1,25-Dihydroxyvitamin D”, J. Bone & Min. Res. 1986 1:377-381.
Smith, A. N., Borthwick, K. J. & Keret, F. E. Molecular cloning and characterization of novel tissue-specific isoforms of the human vacuolar H(+)-ATPase C, G and d subunits, and their evaluation in autosomal recessive distal renal tubular acidosis. Gene 297, 169-177 (2002).
Stevens, T. H. & Forgac, M. Structure, function and regulation of the vacuolar (H+)-ATPase Annu Rev Cell Dev Biol 13, 779-808 (1997).
Suda, T., Jimi, E., Nakamura, I. & Takahashi, N. Role of 1a,25-dihydroxyvitamin D3 in osteoclast differentiation and function. Methods Enzymol. 282, 223-235 (1997).
Sun-Wada, G. H., Yoshimizu, T., Imai-Senga, Y., Wada, Y. & Futai, M. Diversity of mouse proton-translocating ATPase: presence of multiple isoforms of the C, d and G subunits. Gene 302, 147-153 (2003).
Takami, M., Woo, J. T. & Nagai, K. Osteoblastic cells induce fusion and activation of osteoclasts through a mechanism independent of macrophage-colony-stimulating factor production. Cell Tissue Res 298, 327-334 (1999).
Teitelbaum, S. L. Bone resorption by osteoclasts. Science 289, 1504-1508 (2000).
Verrier, S., Hogan, A., McKie, N. & Horton, M. ADAM gene expression and regulation during human osteoclast formation. Bone 35, 34-46 (2004).
Walsh, M. C. et al. Osteoimmunology: Interplay Between the Immune System and Bone Metabolism. Annu Rev Immunol 24, 33-63 (2005).
Yagi, M. et al. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 202, 345-351 (2005).
Cohen Mark S.
Desai Anand
Pearl Cohen Zedek Latzer LLP
The Trustees of The University of Pennsylvania
LandOfFree
OCL-2A3 compositions and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with OCL-2A3 compositions and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and OCL-2A3 compositions and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4268908